Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04722835 · ClinicalTrials.gov registry record

Lung Macrophage Populations and Functions in Chronic Obstructive Pulmonary Disease (COPD)-Susceptible Smokers

A clinical trial, sponsored by University of California, San Francisco.

Recruiting
Registry status
40
Enrollment target

NCT04722835: Recruiting study, sponsored by University of California, San Francisco.

NCT04722835 is a clinical trial that is actively recruiting participants, run by University of California, San Francisco. The registered enrollment target is 40 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04722835 is actively recruiting participants, sponsored by University of California, San Francisco.

RECRUITING
Registry status
40 participants
Enrollment target

Study Summary

Chronic Obstructive Pulmonary Disease (COPD) is a heterogeneous disease that affects only a fraction of those who smoke tobacco. The origin of this variability in susceptibility to develop COPD is unclear, but understanding its underlying biology has important implications for our ability to design suitable preventative and therapeutic strategies for its management. This Department of Defense (DOD) discovery research proposes to develop methodologies and generate preliminary data needed to lay the foundation for a large study that would investigate the underlying biological susceptibility of those who smoke tobacco to develop COPD.

Primary Outcome

Number of macrophages measured by flow cytometry.

Interventions

  • PROCEDURE Bronchoscopy with Bronchoalveolar Lavage (BAL)

Trial Details

FieldValue
Enrollment Target 40 participants
Start Date 2021-03-01
Est. Completion 2030-12-31

What NCT04722835 shows while recruiting

NCT04722835 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 40 participants, a relatively small participant target.

The record links to 0 conditions, and to 1 intervention - of which Bronchoscopy with Bronchoalveolar Lavage (BAL) is the first listed.

NCT04722835 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT04722835 about?

NCT04722835 is a clinical study titled "Lung Macrophage Populations and Functions in Chronic Obstructive Pulmonary Disease (COPD)-Susceptible Smokers". Chronic Obstructive Pulmonary Disease (COPD) is a heterogeneous disease that affects only a fraction of those who smoke tobacco. The origin of this variability in susceptibility to develop COPD is unclear, but understanding its underlying biology has important implications for our ability to design ...

What is the current status of trial NCT04722835?

This trial is currently recruiting. The enrollment target is 40 participants. The study started on 2021-03-01. Estimated completion is 2030-12-31.

What interventions are being tested in trial NCT04722835?

The interventions under investigation include: Bronchoscopy with Bronchoalveolar Lavage (BAL) (PROCEDURE).

Who is sponsoring clinical trial NCT04722835?

This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01306019 · 40 participants · Phase 1

    Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)

  • NCT01608152 · 40 participants

    Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors

  • NCT01668082 · 40 participants · NA

    An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection

  • NCT02015013 · 40 participants · Phase 2

    Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04722835, the US trial registry maintained by the National Library of Medicine. NCT04722835 (small enrollment · none site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.